nSTRIDE® APS is a new and proven treatment that processes your own blood sample and injects it back into your knee joint to alleviate osteoarthritis pain.
nSTRIDE® Autologous Protein Solution (APS) is an autologous treatment for osteoporosis, which means it is ‘from your own body’.
In an osteoarthritic knee, inflammatory “bad” proteins outnumber anti-inflammatory “good” proteins. This imbalance results in knee pain and cartilage degeneration.
nSTRIDE® APS brings balance back to your knee by injecting concentrated high levels of “good” proteins into your inflamed knee joint. These “good” proteins are produced from your own blood. They block the “bad” proteins responsible for your inflammatory joint condition. This decreases pain and slows cartilage degeneration. Other “good” proteins then improve your cartilage health.
The benefits of nSTRIDE® APS are:
• decreases or eliminates pain in your knee joint
• helps to restore mobility, flexibility, and comfort
• less stiffness
• slower cartilage degeneration
• may slow the progression of osteoarthritis
• a single injection in your doctor’s office
The benefits of nSTRIDE® APS should last for 24 to 36 months.
If you suffer from knee joint pain and stiffness due to mild to moderate osteoarthritis and you are looking for a natural and effective treatment, you might think about having nSTRIDE® APS treatment.
nSTRIDE® APS may be right for you if:
Your nSTRIDE® APS treatment will be performed in your orthopaedic knee surgeon’s office and takes 20 to 30 minutes.
A small amount of blood is drawn from a vein in your arm and processed to concentrate white blood cells, platelets, and plasma proteins into a small volume of anti-inflammatory “good” protein solution. This is injected into your affected knee joint area.
nSTRIDE® APS is an outpatient treatment and so you can expect a quick recovery.
After your injection, you may experience some side effects. These can include swelling in your joint, bruising, and local pain associated with drawing your blood draw or your knee injection.
Over the first four to five days, you may experience pain in your injection site or your knee, or both. Do not take nonsteroidal anti-inflammatory drugs (NSAIDs) to manage your pain but you can take other analgesics such as paracetamol.
For the first 14 days, you should keep your activity level to a minimum and not exceed your pre-injection activity levels.
As a minimum, you should limit activities including walking for the first four to five days to prevent inflammation and swelling of your joint. Training and sports should be avoided for at least four to five days after treatment and ideally for 14 days. This is particularly important if you normally participate in high-intensity or long-distance sports or training.
After four to five days, you can expect a small reduction in swelling, stiffness, and pain. You may experience pain relief after one to two weeks. But most patients, feel pain relief between four and eight weeks after treatment.
A significant reduction in pain may take up to eight weeks and can occur suddenly or gradually.
You can expect the benefits from nSTRIDE® APS to last 24 to 36 months.
An arthroscopy allows your surgeon to see inside your knee using a camera inserted through small cuts in the skin.
A partial knee replacement, also known as unicompartmental knee replacement, is surgery that replaces only one damaged compartment in your knee with implants.
Knee replacement is knee surgery to repair worn arthritic knee joints or knee injuries using an artificial knee joint to help reduce pain and restore movement in your knee.
Ramsay Health Care UK are celebrating after being named as a Gold National Joint Registry (NJR) Quality Data Provider after successfully completing a national data quality audit programme for 25 of their hospitals offering orthopaedic procedures.
Newly elected Member of Parliament for Torbay, and Liberal Democrat Work and Pensions Spokesperson Steve Darling MP has visited Ramsay Health Care UK’s Mount Stuart Hospital to see the work of the hospital to deliver for patients across Devon and the wider South West.
Mount Stuart Hospital is celebrating after being named as a National Joint Registry (NJR) Quality Data Provider after successfully completing a national programme of local data audits.